The American Cancer Society has just released its 2018 annual report of cancer statistics in the U.S.
Over the past decade, cancer incidence was stable among women and declined 2 percent annually among men. Over the same period, cancer deaths declined 1.5 percent annually for both women and men.
The combined cancer death rate has dropped continuously from 1991 to 2015 by 26 percent. Of the 10 leading causes of death in the U.S., only cancer declined from 2014 to 2015. ACS attributes this to reduced smoking and advances in prevention, early detection and treatment.
But cancer remains the second-leading cause of death in the U.S. (after heart disease). ACS estimates that 1.74 million Americans will be diagnosed with cancer in 2018, resulting in 600,000 deaths. Men are more susceptible than women; tall people are more susceptible than short people.
Among men, the most common cancers are prostate, lung and colorectal. (Colorectal cancer accounts for almost 1 in 5 new diagnoses.) Among women, the most common cancers are breast, lung and colorectal. (Breast cancer accounts for 30 percent of new diagnoses.)
Cancer remains the leading cause of death among Hispanic and Asian Americans. And there is a significant racial disparity between non-Hispanic blacks and non-Hispanic whites, with a 14 percent higher mortality among NHBs. This disparity is much larger for people younger than 65, probably due to less access to high-quality healthcare.
Agilent is instrumental in researching the causes and treatments for cancer. Agilent Dako products help pathologists make accurate diagnoses and determine the most effective treatment for cancer patients. Agilent cell metabolism (Seahorse) technologies help cancer biology researchers better understand how cancer operates at a cellular level.
Agilent partners with research and clinical facilities worldwide to develop new tools and workflow solutions for discovery and therapeutic development. And we collaborate with pharmaceutical companies to advance tools used to uncover the possible causes of cancer – as well as a multitude of other diseases.
For more information go to: